Ilera Health Enhances Its Team
Pennsylvania’s premiere medical cannabis cultivation and dispensary company, IleraHealthcare, has tapped Dr. Oludare “Dare” Odumosu as Chief Scientific Officer/EVP Pharmaceutical Division. Dr. Odumosu will be charged with driving research, development and implementation of Ilera’s proprietary ‘pharmaceutical-grade’ medicines and therapeutic platforms to the global marketplace.
Dr. Odumosu, who holds a PhD in Biochemistry and a Master’s in Public Health-Epidemiology and Biostatistics, brings 10 years of experience in corporate pharmaceutical business development, operations and strategic alliance management to his new role.
In addition, Tom Borger will be joining the Ilera Healthcare team as their new Chief Operating Officer with a focus on building a world class marketing and retail operation. Borger brings a unique blend of marketing, technology and general management experience and has worked extensively in both start-up and large companies—including Johnson & Johnson and GlaxoSmithKline. He is a Duke graduate who earned his MBA in Entrepreneurial Management/Marketing from the Wharton School of Business, and has taught courses at Wharton’s Small Business Development Center and Villanova’s School of Business. He is the author of an innovation book, Diary of an Innovator—Finding the Path Not Taken and delivered a TEDx talk—“The Power of Inexperience.”
Each person’s experience is unique and there is no universal treatment for PTSD and its symptoms, but an increasing number of experts are recommending cannabis as an incredibly therapeutic treatment for PTSD symptoms.
Christian, a 33-year-old father of four and a Veteran of the United States Army serving eight years, advocates for both medical and recreational marijuana to provide patients with PTSD an alternative to traditional pharmaceuticals.
As the stigma associated with cannabis is slowly fading, and more clinical research studies are being conducted, the benefits of medical marijuana in treating cancer symptoms is becoming apparent in the medical community.